# Regulations.gov document: Reference 8 - Szekely CA, Green RC, Breitner JCS, Østbye T, Beiser AS, Corrada MM, et al. No advantage of
Aβ42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.
Neurology. 2008;70(24):2291-2298. doi:10.1212/01.wnl.0000313933.17796.f6. — retained record

> Retained regulations record from regulations-gov.

Canonical: https://highsignal.app/data/records/caa6da9a3b421553

[← sources](https://highsignal.app/data)

Aβ42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.
Neurology. 2008;70(24):2291-2298. doi:10.1212/01.wnl.0000313933.17796.f6.

source: [regulations](https://highsignal.app/data/regulations) (regulations-gov)  published 2026-08-18 04:00 ingested 2026-08-19 06:29

[original source ↗](https://www.regulations.gov/document/FDA-2026-P-9428-0010)

## retained text



```
Query: data center
Agency: FDA
Type: Supporting & Related Material
Docket: FDA-2026-P-9428
```



document fetched 2026-08-19 06:29 · canonical https://regulations.gov/document/FDA-2026-P-9428-0010